Home / Import refusals / FP1-0020719-9/331/1

FDA Import Refusal FP1-0020719-9/331/1 — Glaxo Operations UK Limited

Glaxo Operations UK Limited — FEI 3003262904

The FDA refused shipment FP1-0020719-9/331/1 from Glaxo Operations UK Limited (United Kingdom) on May 15, 2018. The refused product falls under Drugs and Biologics — LAMIVUDINE (ANTI-VIRAL). Cited charge: 118 This firm has 5 or more other import refusals on record.

Refusal Details

Date
May 15, 2018
Country
United Kingdom
Product Category
Drugs and Biologics
Product Code
62VDA32 LAMIVUDINE (ANTI-VIRAL)
Charges
118

Recent inspections

  • 1267917 (VAI Fri Dec 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1102175 (VAI Fri Sep 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1099616 (VAI Fri Jan 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 935343 (NAI Fri Jul 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 898406 (NAI Fri Sep 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 799-1830807-6/10002/1 (Tue Dec 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • F23-9339962-1/150002/1 (Wed Sep 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • F23-9339758-3/90002/1 (Wed Sep 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-4788090-5/11/1 (Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-0886372-2/11/1 (Fri Feb 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources